Specifically, it upregulated E-cadherin—a key epithelial marker—while downregulating mesenchymal markers like N-cadherin and vimentin at both gene and protein expression levels in HCC LM3 cells. This evidence concerns the gene CDH2 and hepatocellular carcinoma.